Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ONCOTHYREON Inc ONTY

Healthcare Biotechnology
"Oncothyreon Inc is a clinical-stage biopharmaceutical company. It develops and commercializes synthetic vaccines & small molecules that treat the lives & outcomes of cancer patients."

Recent & Breaking News (NDAQ:ONTY)

Oncothyreon and Celldex Therapeutics Announce Initiation of Combination Immunotherapy Clinical Trial of ONT-10 and Varlilumab

GlobeNewswire November 10, 2014

Oncothyreon Reports Third Quarter 2014 Financial Results

GlobeNewswire November 6, 2014

Oncothyreon Announces Third Quarter 2014 Financial Results Conference Call

GlobeNewswire October 30, 2014

Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock

PR Newswire September 18, 2014

Oncothyreon Announces Proposed Public Offerings

PR Newswire September 17, 2014

Oncothyreon to Present at Rodman & Renshaw Global Investment Conference

PR Newswire September 2, 2014

Oncothyreon Inc. (ONTY) Drops 17.27% on August 19

Equities.com August 19, 2014

Oncothyreon Reports Second Quarter 2014 Financial Results

PR Newswire August 11, 2014

Oncothyreon Announces Acquisition of Alpine Biosciences

PR Newswire August 11, 2014

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014

Business Wire August 11, 2014

Oncothyreon Announces Second Quarter 2014 Financial Results Conference Call

PR Newswire August 4, 2014

How the Lack of R&D at Big Pharma Is Boosting Small Biotechs

Equities.com June 14, 2014

Oncothyreon Announces Presentation of ONT-10 Data at ASCO Annual Meeting

PR Newswire June 2, 2014

Oncothyreon and Celldex Therapeutics Announce Collaboration for Combination Immunotherapy Clinical Trial of ONT-10 and Varlilumab

PR Newswire May 29, 2014

Oncothyreon to Present at Jefferies 2014 Global Healthcare Conference

PR Newswire May 28, 2014

Oncothyreon Reports First Quarter 2014 Financial Results

PR Newswire May 1, 2014

Oncothyreon Announces First Quarter 2014 Financial Results Conference Call

PR Newswire April 24, 2014

Oncothyreon Announces Merck KGaA, Darmstadt, Germany, Initiation of Phase 3 START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer

PR Newswire April 7, 2014

Oncothyreon Reports Full Year and Fourth Quarter 2013 Financial Results

PR Newswire March 13, 2014

Oncothyreon Announces Full Year and Fourth Quarter 2013 Financial Results Conference Call

PR Newswire March 6, 2014